Headquarters
90 S 7TH ST STE 3300, MINNEAPOLIS, MN 55402-4104, US
MINNEAPOLIS, MN, US
Diastol Therapeutics, LLC
From the company
Diastol Therapeutics is an emerging biotechnology company developing a treatment for Heart Failure with Preserved Ejection Fraction (HFpEF) as its lead program. Founded in 2018, it is located in Chicago, IL/Minneapolis, MN, and aims to build a cardiovascular-focused company treating leading causes of death and morbidity. Its lead drug candidate is a first-in-class compound with a validated target, with ongoing non-human primate studies and IND filing planned within 18 months of financing.
Products & services offered
Classifications
- Ownership classifications (1)
- Self Certified Small Disadvantaged Business
Facilities
Send your requirements
Quantities, certifications, and timing.